{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"33"}]}],"title":"DCR at 12 weeks"},{"categories":[{"measurements":[{"groupId":"OG000","value":"20"}]}],"title":"DCR at 24 weeks"}],"denoms":[{"counts":[{"groupId":"OG000","value":"61"}],"units":"Participants"}],"description":"Overall, the disease control rate (DCR) (calculated as subjects with CR + subjects with PR + subjects with SD at 12 weeks in duration), and the DCR at 24 weeks.","groups":[{"description":"Subjects with relapsed or refractory BAP1-deficient malignant mesothelioma.","id":"OG000","title":"Part 2"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"The patients were assessed for DCR for up to 24 weeks","title":"Part 2: To Assess Disease Control Rate (DCR) Defined as Number of Subjects With Complete Response (CR), Partial Response (PR) and Stable Disease (SD)","type":"PRIMARY","unitOfMeasure":"Participants"}